Bill Status - 2016 Regular Session

Browse Legislation	Search Bills By	Status & Tracking
All Bills All Resolutions Completed Legislation Actions by Governor Find Legislation	Subject Short Title Sponsor Date Introduced Code Affected All Same As	Floor Activity Committee Activity Roll Call Votes Fiscal Notes Bill Tracking » View Public Comments »

House Bill 2026

	Legislative Session: 2016(RS)
LAST ACTION:	H To House Judiciary 01/15/16
SUMMARY:	Allowing terminally ill patients to have access to investigational products that have not been approved by the federal food and drug administration
LEAD SPONSOR:	Howell
SPONSORS:	Canterbury, Hamrick, Ambler, Zatezalo, McCuskey, Cadle, Evans, D., Rowan, Hartman
BILL TEXT: Bill Definitions	Introduced Version - html \| pdf
CODE AFFECTED:	§16—46—1 (New Code) §16—46—2 (New Code) §16—46—3 (New Code) §16—46—4 (New Code) §16—46—5 (New Code) §16—46—6 (New Code) §16—46—7 (New Code) §16—46—8 (New Code)
COM. AMENDMENTS: Com. Amend. Definitions	HB2026 H H_HR AM _1.htm HB2026 H H&HR AM 1.htm
SUBJECT(S):	Drugs and Drug Paraphernalia Health

ACTIONS:

Chamber	Description	Date	Journal Page
H	To House Judiciary	01/15/16	35
H	With amendment, do pass, but first to Judiciary	01/15/16	35
H	To House Health and Human Resources	01/13/16	35
H	Introduced in House	01/13/16	35
H	To Health and Human Resources then Judiciary	01/13/16
H	Filed for introduction	01/13/16